Virologic effect and hepatotoxicity of BCR::ABL1 tyrosine kinase inhibitors in cancer patients with chronic hepatitis C virus infection: A prospective study

被引：0
|
作者：
Mustafayev, Khalis [1 ]
Guevara, Eduardo Yepez [1 ]
DiNardo, Courtney D. [2 ]
Jabbour, Elias [2 ]
Ghayas, Issa C. [2 ]
Ratan, Ravin [3 ]
Pemmaraju, Naveen [2 ]
Torres, Harrys A. [1 ,4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX USA
来源：
LEUKEMIA RESEARCH | 2024年 / 147卷
关键词：
Dasatinib; Imatinib; Ponatinib; Chronic myeloid leukemia; Viral hepatitis; HCV;
D O I：
10.1016/j.leukres.2024.107597
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN CANCER PATIENTS WITH CHRONIC HEPATITIS C INFECTION: A PROSPECTIVE OBSERVATIONAL STUDY
    Yibirin, Marcel
    Pundhir, Pooja
    Yepez-Guevara, Eduardo
    Granwehr, Bruno
    Kaseb, Ahmed
    Patel, Sapna
    Naing, Aung
    Shah, Amishi Y.
    Skoulidis, Ferdinandos
    Tawbi, Hussein A.
    Zhang, Hao Chi
    Wang, Lan
    Miller, Ethan D.
    Torres, Harrys A.
    HEPATOLOGY, 2020, 72 : 571A - 572A
  • [42] Tern-701 (HS-10382) Is a Potent Inhibitor of BCR::ABL1 and Is Synergistic with Active Site Tyrosine Kinase Inhibitors
    Parsons, Benjamin M.
    Jasper, Jeffrey R.
    Jones, Christopher
    BLOOD, 2023, 142
  • [43] Identification of novel BCR::ABL1 kinase domain mutation in patients with chronic myeloid leukaemia and imatinib resistance
    Yusoff, Yuslina Mat
    Abu Seman, Zahidah
    Anoar, Sharifah Zahra
    Said, Siti Shahrum Muhamed
    Azman, Norazlina
    Kamaluddin, Nor Rizan
    Abdullah, Julia
    Yacob, Aliza Mohd
    Esa, Ezalia
    MALAYSIAN JOURNAL OF PATHOLOGY, 2024, 46 (03) : 431 - 439
  • [44] First-in-Human Study of Elvn-001, a Highly Selective BCR::ABL1 Tyrosine Kinase Inhibitor, in Patients with Chronic Myeloid Leukemia Who Failed Previous Tyrosine Kinase Inhibitor Therapies
    Hughes, Timothy
    Mauro, Michael
    Branford, Susan
    Deng, Wei
    Wang, Qi
    Collins, Helen
    Hochhaus, Andreas
    BLOOD, 2022, 140 : 6780 - 6781
  • [45] Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors
    Kim, Sung-Hyun
    Menon, Hari
    Jootar, Saengsuree
    Saikia, Tapan
    Kwak, Jae-Yong
    Sohn, Sang-Kyun
    Park, Joon Seong
    Jeong, Seong Hyun
    Kim, Hyeoung Joon
    Kim, Yeo-Kyeoung
    Oh, Suk Joong
    Kim, Hawk
    Zang, Dae Young
    Chung, Joo Seop
    Shin, Ho Jin
    Do, Young Rok
    Kim, Jeong-A
    Kim, Dae-Young
    Choi, Chul Won
    Park, Sahee
    Park, Hye Lin
    Lee, Gong Yeal
    Cho, Dae Jin
    Shin, Jae Soo
    Kim, Dong-Wook
    HAEMATOLOGICA, 2014, 99 (07) : 1191 - 1196
  • [46] Study of Abl1 tyrosine kinase inhibitors by liquid chromatography-electrospray ionization-mass spectrometry
    Chen, Hui
    Adams, Erwin
    Van Schepdael, Ann
    TALANTA, 2013, 107 : 88 - 94
  • [47] The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia
    Deregowska, Anna
    Pepek, Monika
    Solarska, Iwona
    Machnicki, Marcin M.
    Pruszczyk, Katarzyna
    Dudzinski, Marek
    Niesiobedzka-Krezel, Joanna
    Seferynska, Ilona
    Sawicki, Waldemar
    Wnuk, Maciej
    Stoklosa, Tomasz
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7103 - 7112
  • [48] The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia
    Anna Deręgowska
    Monika Pępek
    Iwona Solarska
    Marcin M. Machnicki
    Katarzyna Pruszczyk
    Marek Dudziński
    Joanna Niesiobędzka-Krężel
    Ilona Seferyńska
    Waldemar Sawicki
    Maciej Wnuk
    Tomasz Stokłosa
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7103 - 7112
  • [49] BCR/ABL1ΔE7-8-9 isoform contributes to tyrosine kinase inhibitor resistance in chronic myeloid leukemia
    Tan, Yanhong
    Zhang, Lingli
    Zhu, Guiyang
    Yang, Yuchao
    Guo, Wenzheng
    Chen, Lanhui
    Chang, Jianmei
    Xu, Yang
    Muyey, Daniel Muteb
    Wang, Hongwei
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 1067 - 1075
  • [50] Gallic Acid Enhances the Efficacy of BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia through Inhibition of Mitochondrial Respiration and Modulation of Oncogenic Signaling Pathways
    Xiang, Wei
    Sng, Colin
    Lam, Yi-Hui
    Kok, Ze-Hui
    Linn, Yeh-Ching
    Neo, Soek-Ying
    Siew, Yin-Yin
    Singh, Deepika
    Koh, Hwee-Ling
    Chuah, Charles
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
12345